Showing results (41-50 of 183) with videos related to
Sort By:
Pageof 19
British Journal of Haematology|November 20, 2002
Potassium antimonyl tartrate induces caspase- and reactive oxygen species-dependent apoptosis in lymphoid tumoral cellsValérie Lecureur, Aurélien Le Thiec, Alexandre Le Meur, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2010
Front-line high-dose chemotherapy with rituximab showed excellent long-term survival in adults with aggressive large b-cell lymphoma: final results of a Phase II GOELAMS StudyMarie-Sarah Dilhuydy, Thierry Lamy, Charles Foussard, et al.The International Journal of Clinical and Experimental Hypnosis|January 9, 2023
Patients Participating in Nasogastric Tube Insertion through Hypnoanalgesia during High-dose Chemotherapy-induced AplasiaMagali Granger, Norah Anthony, Cécile Lermenier, et al.American Journal of Hematology|June 7, 2006
Spontaneous megakaryocytic colony formation does not discriminate between essential thrombocythemia and polycythemia veraMartine Escoffre-Barbe, Laurence Amiot, Pascale Beaucournu, et al.Human Immunology|November 7, 2003
Soluble HLA-G molecules are increased in lymphoproliferative disordersYasmine Sebti, Gaëlle Le Friec, Céline Pangault, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xLMarion Travert, Patricia Ame-Thomas, Céline Pangault, et al.Plos One|September 27, 2013
BMP7 expression correlates with secondary drug resistance in mantle cell lymphomaValérie Camara-Clayette, Serge Koscielny, Sébastien Roux, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2025
Cefepime Concentration-Toxicity Relationship in Hematological Patients Treated With Continuous Infusion: A Prospective StudySébastien Lalanne, Marie-Noëlle Osmont, Louise Triquet, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2014
COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosisAnne-Sophie Gallouet, Marion Travert, Laurence Bresson-Bepoldin, et al.Cancer|June 16, 2010
Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS)Franck Morschhauser, Nicolas Mounier, Catherine Sebban, et al.Pageof 19